Boehringer Ingelheim caps patient out-of-pocket costs for its …

Ridgefield, Conn., March 7, 2024 – Boehringer Ingelheim today announced it will cap out-of-pocket costs at $35 per month for eligible patients i for all the company’s inhaler products. Boehringer’s new program will dramatically decrease costs at the pharmacy counter for the …

CouponFollow Extension

$35
OFF

Boehringer Ingelheim Caps Patient Out-of-pocket Costs For Its …

1 week from now

boehringer-ingelheim.com

$35
OFF

These Inhalers No Longer Cost More Than $35 Per Month

1 week from now

Mar 26, 2024 · AstraZeneca. AstraZeneca caps patient out-of-pocket costs at $35 per month for its US inhaled respiratory portfolio. Miller is a health and lifestyle journalist with a master's …

verywellhealth.com

$35
OFF

Boehringer To Cap Out-of-pocket Inhaler Cost At $35 Per Month

1 week from now

Mar 7, 2024 · Boehringer Ingelheim will cap out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the German …

reuters.com

$35
OFF

Boehringer Ingelheim Cuts Monthly Out-of-pocket Inhaler Prices To …

1 week from now

Mar 7, 2024 · The German drugmaker will cap patients' out-of-pocket costs at $35 per month for all of its inhaler products, including Atrovent, Combivent, Striverdi, Stiolto and its Sprivia …

fiercepharma.com

$35
OFF

Drugmaker Will Cap Inhaler Costs At $35 Per Month Amid Scrutiny

1 week from now

Mar 7, 2024 · Drugmaker Boehringer Ingelheim plans to cap the out-of-pocket costs for all its inhalers at $35 per month after coming under fire from Democratic lawmakers over pricing. …

thehill.com

$35
OFF

Boehringer Ingelheim To Cap Out Of Pocket Inhaler Costs At $35 …

1 week from now

Mar 7, 2024 · The out-of-pocket price cap applies to all inhalers in the company’s portfolio and will launch on June 1, 2024. Pharmaceutical manufacturer Boehringer Ingelheim has announced a …

drugtopics.com

$35
OFF

Boehringer Ingelheim Caps Patient Out-of-pocket Costs For Its …

1 week from now

RIDGEFIELD, Conn., March 7, 2024 /PRNewswire/ -- Boehringer Ingelheim today announced it will cap out-of-pocket costs at $35 per month for eligible patients i for all the company's inhaler ...

yahoo.com

$35
OFF

Boehringer To Cut Out-of-pocket Costs For Inhalers To $35 - Yahoo …

1 week from now

Mar 7, 2024 · Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German …

yahoo.com

$35
OFF

Boehringer Ingelheim's COPD And Asthma Inhalers Are Now …

1 week from now

RIDGEFIELD, Conn., June 1, 2024 /PRNewswire/ -- Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patients i for the company's inhalers is now available ...

yahoo.com

$35
OFF

Some Drugmakers To Cap Cost Of Asthma Inhalers At $35 A Month

1 week from now

May 31, 2024 · The 6-year-old has severe asthma and needs to use an inhaler twice a day. Lucas’ doctor switched him to a different inhaler, from Merck, which cost $80 a month. Rix is …

nbcnews.com

$35
OFF

Boehringer Ingelheim Sets $35 Cap On Asthma Inhaler Out-of …

1 week from now

Mar 7, 2024 · Boehringer Ingelheim to cap asthma inhaler out-of-pocket costs at $35. F acing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a month …

statnews.com

$35
OFF

Boehringer Ingelheim To Cap Out-of-pocket Inhaler Prices

1 week from now

Mar 7, 2024 · Boehringer Ingelheim has unveiled an initiative to limit the out-of-pocket expenses for eligible patients to $35 per month for its entire range of inhaler medications, starting June …

pharmamanufacturing.com

$35
OFF

CT-based Boehringer Ingelheim To Cap Out-of-pocket Inhaler Costs

1 week from now

Mar 22, 2024 · CT-based Boehringer Ingelheim to cap out-of-pocket inhaler costs at $35, spurred by Senate criticism. By Paul Schott, Staff writer March 22, 2024. Boehringer Ingelheim's U.S. …

ctinsider.com

$35
OFF

Boehringer To Cap Out-of-pocket Inhaler Cost At $35 Per Month

1 week from now

Mar 7, 2024 · Boehringer will also decrease the list price on some of its inhaler products, the company said, without providing further details. The company has cut out-of-pocket costs for …

yahoo.com

$35
OFF

Boehringer Ingelheim's COPD And Asthma Inhalers Are Now …

1 week from now

RIDGEFIELD, Conn., June 1, 2024 /PRNewswire/ -- Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patients i for the company's inhalers is now …

prnewswire.com

$35
OFF

GSK Joins AstraZeneca, Boehringer In Capping US Out-of-pocket …

1 week from now

Mar 21, 2024 · Each drugmaker is capping out-of-pocket costs at $35 per month for their respective inhaler products. GSK's new price cap will take effect no later than January 1, …

fiercepharma.com

$35
OFF

Following Boehringer's Lead, AstraZeneca ⁠caps Monthly Out-of …

1 week from now

Mar 18, 2024 · The plan is to cap monthly out-of-pocket inhaler costs for eligible patients at $35. The move will kick in on June 1 and includes inhaled medicines for both asthma and chronic …

fiercepharma.com

$35
OFF

AstraZeneca To Cap Out-of-pocket Inhaler Costs In US, Following …

1 week from now

March 18 (Reuters) - Drugmaker AstraZeneca (AZN.L) said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, …

reuters.com

FAQs about Boehringer Ingelheim caps patient out-of-pocket costs for its … Coupon?

Will Boehringer Ingelheim cap out-of-pocket costs?

Ridgefield, Conn., June 1, 2024 – Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company’s inhalers is now available. With this program, patients who have had difficulty navigating the current healthcare system will now be able to afford the Boehringer inhalers they need. ...

Will inhalers cap out-of-pocket costs?

The move to cap out-of-pocket costs on inhalers is reminiscent of what insulin manufacturers did last year after coming under fire for exorbitant price hikes. Sanofi, Novo Nordisk, and Eli Lilly all eventually launched programs to cap patient out-of-pocket costs at $35 a month for certain insulin products. Copyright 2024 Nexstar Media Inc. ...

Should Boehringer Ingelheim cap the cost of inhalers?

Now, the senator is pressing Boehringer’s peers AZ, GSK and Teva to follow in its footsteps. “If Boehringer Ingelheim can take action to cap the cost of inhalers at $35 in the United States and lower the list price of some of the inhalers it manufactures, these other companies can do the same,” Sanders said. ...

Which inhaler manufacturers have committed to a $35 price cap?

With the move, three leading inhaler manufacturers have committed to the $35 out-of-pocket monthly price cap. A fourth drugmaker, Teva, was also included in the HELP committee’s January investigation into the “outrageous” costs for asthma and COPD products on the U.S. market. ...

Will GlaxoSmithKline cap the cost of inhalers?

Following years of public outcry about the high cost of inhalers, the two drugmakers — along with a third, GlaxoSmithKline — have committed to capping the out-of-pocket cost at $35 a month. GSK’s cap is expected to take effect by Jan. 1. ...

Will Boehringer & Eli Lilly CAP insulin prices?

Last year, Boehringer and Eli Lilly — the two major insulin makers — announced that they would cap insulin prices at $35 a month. Boehringer had also said it would cap out-of-pocket costs for its inhaler products for chronic lung disease and asthma to $35 per month, starting June 1. ...